Jiangsu Nhwa Pharmaceutical Co Ltd (002262) - Total Liabilities

Latest as of March 2026: CN¥1.30 Billion CNY ≈ $189.81 Million USD

Based on the latest financial reports, Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has total liabilities worth CN¥1.30 Billion CNY (≈ $189.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 002262 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Jiangsu Nhwa Pharmaceutical Co Ltd - Total Liabilities Trend (2005–2025)

This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Jiangsu Nhwa Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Jiangsu Nhwa Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Nhwa Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
TELEPERFORMANCE SE ADR F:RCF0	Germany	€7.38 Billion
International Game Technology PLC NYSE:IGT	USA	$9.23 Billion
Glory View Technology Co. Ltd. A SHE:301396	China	CN¥2.34 Billion
Fujian Longking Co Ltd SHG:600388	China	CN¥17.37 Billion
Berner Kantonalbank AG SW:BEKN	Switzerland	CHF39.89 Billion
Energix Renewable Energies Ltd TA:ENRG	Israel	ILA10.61 Billion
Jiangxi Jovo Energy Co. Ltd SHG:605090	China	CN¥5.66 Billion
Denali Therapeutics Inc NASDAQ:DNLI	USA	$339.93 Million

Liability Composition Analysis (2005–2025)

This chart breaks down Jiangsu Nhwa Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jiangsu Nhwa Pharmaceutical Co Ltd (002262) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.69	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Nhwa Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

The table below shows the annual total liabilities of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.20 Billion ≈ $174.92 Million	+2.47%
2024-12-31	CN¥1.17 Billion ≈ $170.69 Million	+27.06%
2023-12-31	CN¥918.09 Million ≈ $134.35 Million	+2.30%
2022-12-31	CN¥897.43 Million ≈ $131.32 Million	+13.10%
2021-12-31	CN¥793.45 Million ≈ $116.11 Million	+12.28%
2020-12-31	CN¥706.67 Million ≈ $103.41 Million	+18.43%
2019-12-31	CN¥596.68 Million ≈ $87.31 Million	-44.48%
2018-12-31	CN¥1.07 Billion ≈ $157.26 Million	+27.90%
2017-12-31	CN¥840.24 Million ≈ $122.95 Million	-1.26%
2016-12-31	CN¥850.97 Million ≈ $124.52 Million	+17.60%
2015-12-31	CN¥723.60 Million ≈ $105.89 Million	-16.21%
2014-12-31	CN¥863.61 Million ≈ $126.37 Million	+18.28%
2013-12-31	CN¥730.13 Million ≈ $106.84 Million	+10.22%
2012-12-31	CN¥662.41 Million ≈ $96.93 Million	+23.22%
2011-12-31	CN¥537.59 Million ≈ $78.67 Million	+9.32%
2010-12-31	CN¥491.74 Million ≈ $71.96 Million	+27.83%
2009-12-31	CN¥384.68 Million ≈ $56.29 Million	-0.25%
2008-12-31	CN¥385.66 Million ≈ $56.43 Million	-13.22%
2007-12-31	CN¥444.39 Million ≈ $65.03 Million	+16.44%
2006-12-31	CN¥381.63 Million ≈ $55.85 Million	+6.86%
2005-12-31	CN¥357.12 Million ≈ $52.26 Million	--

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.30 Billion

CN¥22.58 Billion CNY

Market Cap Rank

#4589 Global

#733 in China

Share Price

CN¥22.23

Change (1 day)

+0.59%

52-Week Range

CN¥18.23 - CN¥28.92

All Time High

CN¥31.19